Poseida Therapeutics, Inc.
PSTX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$123 | -$64 | -$125 | -$130 |
| Dep. & Amort. | $6 | $5 | $5 | $3 |
| Deferred Tax | $0 | $0 | -$20 | $0 |
| Stock-Based Comp. | $23 | $19 | $17 | $7 |
| Change in WC | $14 | $14 | $20 | $6 |
| Other Non-Cash | -$12 | -$1 | $1 | $1 |
| Operating Cash Flow | -$92 | -$27 | -$103 | -$113 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$4 | -$3 | -$17 |
| Net Acquisitions | $0 | $0 | $0 | $188 |
| Inv. Purchases | -$238 | -$294 | -$0 | -$295 |
| Inv. Sales/Matur. | $280 | $95 | $225 | $108 |
| Other Inv. Act. | $0 | -$199 | $0 | -$188 |
| Investing Cash Flow | $39 | -$203 | $222 | -$204 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $30 | $0 | $0 |
| Stock Issued | $15 | $75 | $3 | $206 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | -$0 | $3 | $108 |
| Financing Cash Flow | $16 | $105 | $3 | $314 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$37 | -$125 | $122 | -$4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $81 | $206 | $84 | $88 |
| End Cash | $44 | $81 | $206 | $84 |
| Free Cash Flow | -$95 | -$31 | -$105 | -$130 |